abc27

NobleStitch™ Suture-Mediated PFO Closure Demonstrates Superior Long-Term Safety and Outcomes in Largest Cohort to Date

While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...
Frontiers

Patent Foramen Ovale: Advances in Mechanisms, Diagnosis, and Therapy

Patent Foramen Ovale (PFO) is a common congenital cardiac anatomical variant present in approximately 25% of the general ...

NobleStitch™ Suture-Mediated PFO Closure Demonstrates Superior Long-Term Safety and Outcomes in Largest Cohort to Date

NobleStitch™, the deviceless suture-mediated patent foramen ovale (PFO) closure system distributed worldwide by HeartStitch, Inc., today announces robust long-term clinical results from the largest ...